As a medical technology company based in Austria, A.M.I. Agency for Medical Innovations has been engaged in the development and production of medical innovations and surgical solutions in the fields of Coloproctology, Urology and Urogynecology for over 20 years. With high quality products, A.M.I. contributes to improving surgical procedures and enhancing patients’ quality of life. The foundation for this is the maximum quality standards and the goal of achieving perfection of the product.
Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.
AURIMOD is a commercial stage medical device company from Vienna, Austria, offering user centric solutions for pain patients. Our product VIVO offers unique minimally invasive and personalized chronic pain treatment. VIVO is a wearable neuromodulation device to be worn behind the ear utilizing auricular vagus nerve stimulation (aVNS). VIVO allows non-pharmacological treatment of chronic low back pain and migraine with a clinically proven and sustainable therapeutic effect.
AVVie GmbH is developing a novel minimally invasive implant aimed at addressing a prolific heart valve condition affecting millions worldwide.